Skip to main content

Shorter Courses of Radiotherapy Increasingly Used for Prostate Cancer

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Oct. 10, 2023 -- From 2004 to 2020, there was an increase in the use of shorter radiotherapy (RT) courses (hypofractionation) for prostate cancer, according to a brief report published online Oct. 5 in JAMA Oncology.

James B. Yu, M.D., from St. Francis Hospital in Hartford, Connecticut, and colleagues used data from the National Cancer Database to identify the current practice patterns of external beam RT for prostate cancer in the United States. The analysis included 313,062 patients with localized prostate cancer.

The researchers identified a significant temporal pattern of decline in the proportion of patients who received conventional fractionation from 2004 to 2020 (76.0 to 36.6 percent). During the same period, use of moderate hypofractionation and ultrahypofractionation significantly increased (from 22.0 to 45.0 percent and from 2.0 to 18.3 percent, respectively). For patients in the low- and intermediate-risk groups, the most common RT schedule by 2020 was ultrahypofractionation and moderate hypofractionation, respectively. Shorter courses of RT were seen in association with treatment at a community cancer program versus academic or research program, Medicaid versus Medicare insurance, Black versus White race, and higher versus lower median income.

"Reduced adoption was associated with multiple social determinants of health," the authors write. "Realignment of value-based models to appropriately increase reimbursement for hypofractionation may reduce barriers to nationwide adoption and may ensure access to this treatment for underserved communities."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

First Responders With More Debris Exposure Have Higher Risk of Early Dementia

FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...

1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM

FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.